U.S. market Closed. Opens in 2 hours 40 minutes

ABOS | Acumen Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/A1.44M1.70M
Cost of Revenue42.32M169.00K4.00K8.00K8.58K
Gross Profit-42.32M-169.00K-4.00K1.43M1.69M
Operating Expenses61.14M45.24M19.58M9.35M9.50M
Selling, General & Admin18.82M12.88M7.28M1.35M926.00K
Research & Development42.32M32.36M12.30M8.00M8.58M
Other Operating ExpensesN/A-11.00K51.00KN/AN/A
Operating Income-61.14M-45.24M61.57M-7.91M-7.80M
Other Expenses / Income8.77M2.38M-81.02M587.00K-102.00K
Before Tax Income-52.37M-42.86M-100.61M-7.33M-7.91M
Income Tax ExpensesN/A-2.38M81.07M-1.00K-45.00K
Net Income-52.37M-40.48M-181.68M-7.32M-7.86M
Interest ExpensesN/AN/AN/AN/AN/A
Basic Shares Outstanding48.49M40.60M40.47M40.15M40.15M
Diluted Shares Outstanding48.61M40.60M40.47M40.15M40.15M
EBITDA-51.61M-42.69M61.58M587.00K119.00K
EBITDA Margin0.00%0.00%0.00%40.88%7.01%
EBIT-52.37M-42.86M-100.61M-7.33M-7.91M
EBIT Margin0.00%0.00%0.00%-510.10%-465.94%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙